CO
CORT
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Ray Dalio | Bridgewater Associates | $5M | 0.0% | 2026-06-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Methodology breakdown computing — it will appear here on its own.
Corcept Therapeutics Inc (CORT) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-07-31). See the full ratio breakdown and business-activity screen below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for CORT — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 54.90 | NEUTRAL |
| Stochastic %K (14) | 36.79 | NEUTRAL |
| CCI (20) | -23.74 | NEUTRAL |
| Williams %R (14) | -63.21 | NEUTRAL |
| MACD (12,26,9) | -1.22 | SELL |
| ROC (10) | -4.07 | SELL |
| Momentum (10) | -4.88 | SELL |
| EMA (10) | 114.54 | BUY |
| SMA (10) | 113.70 | BUY |
| EMA (20) | 113.85 | BUY |
| SMA (20) | 116.31 | SELL |
| EMA (30) | 111.44 | BUY |
| SMA (30) | 114.98 | SELL |
| EMA (50) | 104.95 | BUY |
| SMA (50) | 105.72 | BUY |
| EMA (100) | 91.25 | BUY |
| SMA (100) | 85.16 | BUY |
| EMA (200) | 78.92 | BUY |
| SMA (200) | 67.41 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
About Corcept Therapeutics Inc
Healthcare · Biotechnology
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig's disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.
Background via Yahoo Finance — informational, not part of the verdict.
Latest Signal — 2026-08-26
⚪ NEUTRAL — No Edge
Signals are mixed with no clear edge in either direction. Stand aside and wait for one more confluence factor.
Scores: 2 bullish / 2 bearish
Weak — low conviction, small size or skip
SMC — Top Down
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | RANGING | 62 |
| ⏰ 4H | BULLISH | 37 |
| 🕐 1H | BULLISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Insider Activity (90d)
CLUSTER SELL 0 buys · 41 sells
Recent: WILSON JAMES N sold 1084543 sh @ $89.49 (2026-07-15); WILSON JAMES N sold 1086521 sh @ $88.81 (2026-07-15); WILSON JAMES N sold 1089495 sh @ $87.74 (2026-07-15)
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.